Home > Income Statement > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
Consolidated Net Profit

    Back to Income Statement
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

BALAXI PHARMACEUTICALS Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹-7.31 Cr₹52 Cr₹48 Cr₹37 Cr₹6.13 Cr

What is the latest Consolidated Net Profit of BALAXI PHARMACEUTICALS ?

The latest Consolidated Net Profit ratio of BALAXI PHARMACEUTICALS is ₹-7.31 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹-7.31 Cr
Mar2024₹52 Cr
Mar2023₹48 Cr
Mar2022₹37 Cr
Mar2021₹6.13 Cr

How is Consolidated Net Profit of BALAXI PHARMACEUTICALS Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹-7.31 Cr
Negative
Mar2024 ₹52 Cr
7.39
Mar2023 ₹48 Cr
29.41
Mar2022 ₹37 Cr
507.51
Mar2021 ₹6.13 Cr -

Compare Consolidated Net Profit of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹91.0 Cr -6.6% -17.7% -74.4% Stock Analytics
ADANI ENTERPRISES ₹235,637.0 Cr -5.4% -16.5% -17.7% Stock Analytics
REDINGTON ₹15,698.0 Cr -7.6% -16.3% -15.5% Stock Analytics
HONASA CONSUMER ₹9,700.9 Cr 3% -2.5% 33.1% Stock Analytics
MMTC ₹8,277.0 Cr -7.7% -10.5% 3.9% Stock Analytics
LLOYDS ENTERPRISES ₹6,498.5 Cr -6% -21.2% 11.2% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

-6.6%

-17.7%

-74.4%

SENSEX

-0.8%

-11.7%

-3.6%


You may also like the below Video Courses